Already marketed in the United States and Europe, the iTind procedure is a minimally invasive solution for the treatment of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. With ...

CENTER VALLEY, Pa., Sept. 11, 2025 /PRNewswire/ -- During National Prostate Health Month in September, Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) ...

A literature search was carried out for this briefing in accordance with the interim process and methods statement for medtech innovation briefings. This briefing includes the most relevant or best ...

Performed in Mulgrave for the first time in Victoria on April 20, Associate Professor Sree Appu used the newly developed iTind implant to widen the urethra opening without burning or cutting the ...

CENTER VALLEY, Pa. , Oct. 20, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today ...

In addition, three regional health plans updated their policies. These positive policy updates affect approximately 2 million more lives across Delaware, Florida, North Carolina, Pennsylvania, South ...

CENTER VALLEY, Pa., May 13, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today that its ...

CENTER VALLEY, Pa., Sept. 20, 2021 /PRNewswire/ — Olympus has been selected to exhibit the iTind TM device, a temporarily implanted device for relief of enlarged prostate symptoms, at the Vizient ...

(MENAFN- JCN NewsWire) Olympus Announces Milestone for iTind(TM) Device with Expanded Availability Across Major APAC Markets Strengthening Access to Minimally Invasive BPH Treatment SINGAPORE, Feb 26, ...

iTind (Olympus) is a temporary implanted nitinol device. Using local anaesthesia or light sedation, the folded device is inserted into the bladder under direct visualisation using a cystoscope. The ...